How To Foster Greater R&D And CMC Integration In Your Organization

In this Bioprocess Online Live panel discussion, John Stubenrauch, Ph.D., Chief Operations Officer at Nutcracker Therapeutics, Hari Pujar, Ph.D., Chief Operating Officer at Tessera, and Anna Rose Welch, Chief Editor at Cell & Gene Collaborative discuss go-to best practices, suggestions, and experiences for prioritizing and streamlining technical operations endeavors to prepare for the clinic and, eventually, the commercial market. Here, Stubenrauch and Pujar outline how they encourage their CMC and R&D teams to work more closely together to ensure a streamlined transition of a molecule from R&D to process development.

View the full presentation here.